Physician profile
David D Tran
NPI 1275577751
$960.26
in general payments reported to CMS, 2019-2025
8 companies · $269 in 2025
The $269 reported for 2025 was more than what 87% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $142 · 2021: $111 · 2022: $16.90 · 2023: $251 · 2024: $170 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $350.39 | 2024-2025 | Novosorb Btm |
| Davol INC. | $251.01 | 2023 | Phasix Mesh |
| Inari Medical, INC. | $142.17 | 2020 | |
| Integra Lifesciences Corporation | $89.01 | 2021 | |
| Ceribell, INC. | $48.10 | 2025 | Pocket Eeg Device |
| Abbvie INC. | $38.50 | 2021-2022 | |
| Convatec INC. | $21.46 | 2025 | |
| Novo Nordisk INC | $19.62 | 2025 | Rybelsus, Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.